Biotherapeutic Agents and Infectious Diseases

Lieferzeit: Lieferbar innerhalb 14 Tagen

106,99 

ISBN: 1475746520
ISBN 13: 9781475746525
Herausgeber: Gary W Elmer/Lynne McFarland/Christina Surawicz
Verlag: Humana Press
Umfang: xii, 316 S.
Erscheinungsdatum: 31.01.2013
Auflage: 1/1999
Produktform: Kartoniert
Einband: KT

In Biotherapeutic Agents and Infectious Diseases, leading investigators active in the discovery, development, and application of this novel class of anti-infective agents concisely review the use of these special microorganisms in treating human disease. Focusing on biotherapeutic entities that have been tested in controlled studies, the prominent experts illuminate the scientific underpinnings of their therapeutic potential, assess their possible risks in the treatment of infectious diseases, and outline the research needed to better define their effectiveness. In addition, they also consider biotherapeutic agents may be genetically engineered for maximum intestinal and vaginal production of bioactive substances in vivo. Biotherapeutic Agents and Infectious Diseases brings together all the evidence needed to understand and capitalize on the considerable promise of this significant new class of biotherapeutic entities. As an alternative to antibiotics that increasingly lead to drug-resistant pathogens, the living microorganisms described in this timely and authoritative book will significantly aid today’s clinicians in the prevention and treatment of infectious diseases.

Artikelnummer: 5454138 Kategorie:

Beschreibung

Authoritative investigators active in the discovery, development, and application of biological anti-infective agents concisely review their use and potential in preventing and treating human disease. Focusing on biotherapeutic entities that have been tested in controlled studies, the prominent experts illuminate the scientific underpinnings of their therapeutic power, assess their possible risks in the treatment of infectious diseases, and outline the research needed to better define their effectiveness. In addition, they also consider how biotherapeutic agents may be genetically engineered for maximum intestinal and vaginal production of bioactive substances in vivo. Biotherapeutic Agents and Infectious Diseases brings together all the evidence needed to understand and capitalize on the considerable promise of this significant new class of biotherapeutic entities.

Das könnte Ihnen auch gefallen …